Skip to Main Content

Paper Details

The ASSESS-AKI Study found urinary epidermal growth factor is associated with reduced risk of major adverse kidney events.
Kidney Int
2
2023
AKI, Acute Kidney Injury, CKD, Cr, EGF, Egf, MAKE, Participants, atrophy, chronic kidney disease, epidermal growth factor, ischemia-reperfusion injury, kidney atrophy, kidney failure, mice, mouse, participants, patients, uEGF, urinary EGF, urinary epidermal growth factor
Author NameAffiliation
Dennis G MoledinaYale University School of Medicine
Heather Thiessen-PhilbrookJohns Hopkins University School of Medicine
Pavan K BhatrajuUniversity of Washington, USA Kidney Research Institute
Talat Alp IkizlerVanderbilt University Medical Center
Edward D SiewVanderbilt University Medical Center
Amit X GargWestern University
Alan S GoUniversity of California San Francisco, Kaiser Permanente Northern California
Kathleen D LiuUniversity of California San Francisco
Jonathan HimmelfarbKidney Research Institute, University of Washington
Jonathan HimmelfarbKidney Research Institute, University of Washington
Lloyd G CantleyYale University School of Medicine
Chirag R ParikhJohns Hopkins University School of Medicine
  • 1 - 12

Datasets

Release 1.2